Schedule 13G ownership disclosure

VISTAGEN THERAPEUTICS INC

Security class unavailable · CUSIP: 92840H202

Event date: 2018-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
8.9800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001178913-19-000442
Form type
SC 13G/A
Filer
SPHERA FUNDS MANAGEMENT LTD.
CIK
CIK 1496201
Filed
Feb 13, 2019
Reporting period
Dec 31, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub